Ron Kelly

Chief Executive Officer & Board Member

ron.kelly@ambature.com

Ron is the Chief Executive Officer of Ambature, Inc. He is a performance-driven executive with over 29 years of experience in technology development, technology licensing and corporate and intellectual property law in North America and around the World.

He has extensive experience negotiating technology licensing with multinational corporations such as IBM, GE, Philips, Siemens, Johnson & Johnson, Essilor Laboratories, Burmah Castrol and McKinsey. Ron has recently consulted with government officials in the US, Canada and the UK, helping them understand the role disruptive information technology plays in creating greater quality and efficiency in the healthcare industry.

He is the former President, CEO and Chairman of Medicalis Corporation, a leading disruptive healthcare technology company based in Waterloo, Ontario (Canada’s technology triangle). Prior to joining Medicalis, Ron served in various board and management positions in companies involved in the licensing of various technologies, including laser vision correction technologies, non-cancerous lignin polymers, e-commerce and software licensing. Ron is a graduate of Dalhousie University with a combined Masters of Business Administration (International Business and Finance) and Juris Doctorate degree.

He also holds an honors undergraduate degree in Finance and Management from the Memorial University of Newfoundland. Upon graduation, he was recruited by Canada’s largest law firm and focused on corporate finance and intellectual property for clients such as Walt Disney, Pepsi and the Government of Canada.